https://www.businesswire.com/news/home/20200528005462/en/Clovis-Oncology-Announces-New-Recommendations-Rubraca%C2%AE-rucaparib
0
0
5/28/20 at 5:10am
Organization
Business Wire
Authors
BOULDER, Colo.--(BUSINESS WIRE)---- $CLVS--Clovis Oncology, Inc. (NASDAQ: CLVS), announced today that the National Comprehensive Cancer Network® (NCCN) updated its Clinical Practice Guidelines in Oncology for Prostate Cancer to include new recommendations for…
Create an account
or login to join the discussion